// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Is the poly parenthood the new type of parenthood?

C Herbrand - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evidence based management of endometriosis – what has changed since 2013?

C Becker - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gynaecological cancer

N/A

The GnRH-agonist trigger alone can be used for egg maturation in altruistic egg donors using long-acting reversible contraceptives without compromising the outcome

M Mascarenhas - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Ovarian hyperstimulation syndrome

N/A

From insult to injury: war and cross border reproductive care (CBRC. Difficulties for patients and collaborators

F Shenfield - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Men’s fertility knowledge and attitudes to starting a family in Greece, Nepal and the UK

R Biswakarma - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Infertility

N/A

The effect of sperm DNA quality on blastocyst and euploid rates

H Exeter - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of oxygen levels, temperature, and interruptive evaluation practices during embryo culture on embryo developmental arrest. A systematic review and network meta-analysis

T Vaxevanoglou - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Could day 7 embryo culture become standard practice to improve patients’ treatment and outcome?

O Delikari - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical factors influencing the incidence of tripronuclear zygotes in IVF

C Passaro - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ICM segmentation is impacted by several factors for humans as well for AI models but AI models show consistency

C Jacques - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Blastocyst transfer in advanced maternal age: Single versus double embryo transfer

D Balfoussia - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Laboratory performance in PGT-SR cases in carriers of chromosomal rearrangements

K Douglas - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

Quantitative analysis of uterine peristalsis using optical flow for motion quantification

S Latif - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Adenomyosis

N/A

How to define recurrent implantation failure and when to start investigating the endometrium? Lessons from three years’ experience in a dedicated unit

M Rahmati - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

Predicting live birth following single euploid frozen blastocyst transfer - does the journey matter?

E Theodorou - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

Comparative analysis of serum obtained in early pregnancy using Fourier transform-infrared spectroscopy to predict tubal ectopic pregnancy and miscarriage

C Lima - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ectopic pregnancy

N/A

EndoTime: Non-categorical timing estimates for luteal endometrium

A Mitchell - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

Testosterone treatment induces changes in stromal collagen and elastin content of the ovaries of transgender men

E Bailie - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

LPCN 1111

Patient Care Guidance: Development of a unique tool for fertility clinics based on best practice evidence

G Baccino - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A survey of women’s experiences, behaviours and attitudes of using period tracker applications (apps

J Harper - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved